Home › Stock analysis › BNR
Burning Rock Biotech (BNR) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
What changed since yesterday
- Closed at $12.90, -17.31% vs the prior close of $15.60.
- Volume 24.91K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BNR slides 17.3% to $12.90, a 1-month low. Closed at $12.90, -17.31% vs the prior close of $15.60. Day range $12.60–$15.91, opened at $15.91.
Last close$12.90-17.31%
Day range12.60–15.91
Open15.91
Volume24.91K
52-week range6.79–41.72
Avg volume (20d)34.34K
BNR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — BNR slides 17.3% to $12.90, a 1-month low
- Closed at $12.90, -17.31% vs the prior close of $15.60. Day range $12.60–$15.91, opened at $15.91.
- Volume was 24.91K shares, 0.7x its 50-day average of 35.65K.
- Price is +1.2% vs its 50-day average ($12.74) and -23.8% vs its 200-day average ($16.92).
- 52-week range $6.79–$41.72; today's close sits at 17% of that range, 69.1% below the 52-week high.
Oct 15, 2026 — BNR jumps 6.8% to $15.60 on 2.1x normal volume
- Closed at $15.60, +6.78% vs the prior close of $14.61. Day range $14.61–$16.36, opened at $14.61.
- Volume was 73.40K shares, 2.1x its 50-day average of 34.22K — unusually heavy trading.
- Price is +23.2% vs its 50-day average ($12.66) and -8.0% vs its 200-day average ($16.96).
- 52-week range $6.79–$41.72; today's close sits at 25% of that range, 62.6% below the 52-week high.
Oct 14, 2026 — BNR dips 2.6% to $14.61, 3 down days in a row
- Closed at $14.61, -2.60% vs the prior close of $15.00. Day range $13.92–$15.05, opened at $14.29.
- Volume was 15.00K shares, 0.4x its 50-day average of 33.97K — lighter than usual.
- Price is +16.6% vs its 50-day average ($12.53) and -14.0% vs its 200-day average ($16.98).
- 52-week range $6.79–$41.72; today's close sits at 22% of that range, 65.0% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — BNR ends flat (+0.0%) to $15.00
- Closed at $15.00, +0.00% vs the prior close of $15.00. Day range $13.87–$15.05, opened at $14.79.
- Volume was 13.30K shares, 0.4x its 50-day average of 33.99K — lighter than usual.
- Price is +20.8% vs its 50-day average ($12.41) and -11.8% vs its 200-day average ($17.01).
- 52-week range $6.79–$41.72; today's close sits at 24% of that range, 64.0% below the 52-week high.
Oct 12, 2026 — BNR slides 3.2% to $15.00
- Closed at $15.00, -3.16% vs the prior close of $15.49. Day range $15.00–$15.59, opened at $15.59.
- Volume was 3.90K shares, 0.1x its 50-day average of 33.94K — lighter than usual.
- Price is +22.0% vs its 50-day average ($12.29) and -12.0% vs its 200-day average ($17.05).
- 52-week range $6.79–$41.72; today's close sits at 24% of that range, 64.0% below the 52-week high.
Oct 9, 2026 — BNR rises 1.9% to $15.49
- Closed at $15.49, +1.91% vs the prior close of $15.20. Day range $14.79–$15.82, opened at $14.79.
- Volume was 7.70K shares, 0.2x its 50-day average of 33.83K — lighter than usual.
- Price is +27.3% vs its 50-day average ($12.17) and -9.3% vs its 200-day average ($17.08).
- 52-week range $6.79–$41.72; today's close sits at 25% of that range, 62.9% below the 52-week high.
Oct 8, 2026 — BNR ends flat (+0.1%) to $15.20
- Closed at $15.20, +0.13% vs the prior close of $15.18. Day range $14.41–$15.21, opened at $15.18.
- Volume was 14.10K shares, 0.4x its 50-day average of 33.58K — lighter than usual.
- Price is +26.3% vs its 50-day average ($12.04) and -11.2% vs its 200-day average ($17.12).
- 52-week range $6.79–$41.72; today's close sits at 24% of that range, 63.6% below the 52-week high.
Oct 7, 2026 — BNR slides 5.8% to $15.18
- Closed at $15.18, -5.77% vs the prior close of $16.11. Day range $15.18–$16.29, opened at $16.29.
- Volume was 10.70K shares, 0.3x its 50-day average of 33.40K — lighter than usual.
- Price is +27.5% vs its 50-day average ($11.91) and -11.5% vs its 200-day average ($17.15).
- 52-week range $6.79–$41.72; today's close sits at 24% of that range, 63.6% below the 52-week high.
Oct 6, 2026 — BNR rises 1.8% to $16.11
- Closed at $16.11, +1.80% vs the prior close of $15.82. Day range $15.98–$18.00, opened at $15.98.
- Volume was 32.00K shares, 1.0x its 50-day average of 32.77K.
- Price is +36.7% vs its 50-day average ($11.79) and -6.2% vs its 200-day average ($17.18).
- 52-week range $6.79–$41.72; today's close sits at 27% of that range, 61.4% below the 52-week high.
Oct 5, 2026 — BNR dips 2.6% to $15.82
- Closed at $15.82, -2.62% vs the prior close of $16.25. Day range $15.60–$16.66, opened at $16.09.
- Volume was 49.10K shares, 1.5x its 50-day average of 31.79K.
- Price is +35.8% vs its 50-day average ($11.65) and -8.0% vs its 200-day average ($17.20).
- 52-week range $6.79–$41.72; today's close sits at 26% of that range, 62.1% below the 52-week high.
Oct 2, 2026 — BNR rises 1.6% to $16.25
- Closed at $16.25, +1.63% vs the prior close of $15.99. Day range $16.05–$16.79, opened at $16.36.
- Volume was 15.30K shares, 0.5x its 50-day average of 31.62K — lighter than usual.
- Price is +41.1% vs its 50-day average ($11.52) and -5.6% vs its 200-day average ($17.21).
- 52-week range $6.79–$41.72; today's close sits at 27% of that range, 61.0% below the 52-week high.
BNR latest news & SEC filings
Every SEC filing by or about BNR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 10, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Han Yusheng bought 24,900 shares at $8.00 (≈$199.20K) on Jun 26, 2026
- Han Yusheng bought 24,900 shares at $8.00 (≈$199.20K) on Jun 26, 2026
- Han Yusheng bought 24,900 shares at $8.00 (≈$199.20K) on Jun 26, 2026
- Han Yusheng bought 24,900 shares at $8.00 (≈$199.20K) on Jun 26, 2026
- Han Yusheng bought 250,000 shares at $8.00 (≈$2.00M) on Jun 24, 2026
- Han Yusheng bought 250,000 shares at $8.00 (≈$2.00M) on Jun 24, 2026
- …plus 19 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade BNR
- How much it moves: over the last 20 sessions the average daily move was 5.94% (largest 19.4%). That is a volatile stock.
- Liquidity: about 34.34K shares (≈$442.99K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $12.90 vs a range of $6.79–$41.72 (17% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Yusheng Han bought 24,900 shares on Jun 26, 2026.
- Latest filings: 6-K Sep 10, 2026; 6-K Jun 9, 2026; 20-F Apr 28, 2026.
- Listing: Nasdaq · industry: Services-Medical Laboratories.
BNR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 15.91 | 15.91 | 12.60 | 12.90 | 24.91K |
| Oct 15, 2026 | 14.61 | 16.36 | 14.61 | 15.60 | 73.40K |
| Oct 14, 2026 | 14.29 | 15.05 | 13.92 | 14.61 | 15.00K |
| Oct 13, 2026 | 14.79 | 15.05 | 13.87 | 15.00 | 13.30K |
| Oct 12, 2026 | 15.59 | 15.59 | 15.00 | 15.00 | 3.90K |
| Oct 9, 2026 | 14.79 | 15.82 | 14.79 | 15.49 | 7.70K |
| Oct 8, 2026 | 15.18 | 15.21 | 14.41 | 15.20 | 14.10K |
| Oct 7, 2026 | 16.29 | 16.29 | 15.18 | 15.18 | 10.70K |
| Oct 6, 2026 | 15.98 | 18.00 | 15.98 | 16.11 | 32.00K |
| Oct 5, 2026 | 16.09 | 16.66 | 15.60 | 15.82 | 49.10K |
| Oct 2, 2026 | 16.36 | 16.79 | 16.05 | 16.25 | 15.30K |
| Oct 1, 2026 | 17.83 | 18.01 | 15.99 | 15.99 | 38.80K |
| Sep 30, 2026 | 18.60 | 18.70 | 17.63 | 17.63 | 13.80K |
| Sep 29, 2026 | 17.55 | 19.45 | 17.35 | 18.94 | 58.70K |
| Sep 28, 2026 | 18.23 | 18.60 | 17.30 | 17.63 | 86.30K |
| Sep 25, 2026 | 17.79 | 19.60 | 17.33 | 18.60 | 39.50K |
| Sep 24, 2026 | 15.52 | 18.65 | 14.47 | 18.00 | 136.00K |
| Sep 23, 2026 | 16.44 | 16.45 | 14.35 | 15.07 | 24.10K |
| Sep 22, 2026 | 15.08 | 16.85 | 15.08 | 16.45 | 20.20K |
| Sep 21, 2026 | 14.47 | 15.43 | 14.47 | 14.73 | 10.00K |
About Burning Rock Biotech
Burning Rock Biotech (BNR) is listed on the Nasdaq and classified by the SEC under “Services-Medical Laboratories”. Its business address is in GUANGZHOU, GUANGDONG. Fiscal year ends —. SEC CIK 1792267.
BNR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Feng Deng | Director | Mar 18, 2026 |
| Yusheng Han | Director | Jul 2, 2026 |
| Wendy W. Hayes | Director | Mar 17, 2026 |
| Licen Lisa Xu | Director | Mar 17, 2026 |
| Zhihong Zhang | Director | Mar 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Xiaozhi Hu | Senior Director in Finance | Mar 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 26, 2026 | Yusheng Han | Buy | 24,900 | $8.00 |
| Jun 26, 2026 | Yusheng Han | Buy | 24,900 | $8.00 |
| Jun 26, 2026 | Yusheng Han | Buy | 24,900 | $8.00 |
| Jun 26, 2026 | Yusheng Han | Buy | 24,900 | $8.00 |
| Jun 24, 2026 | Yusheng Han | Buy | 250,000 | $8.00 |
| Jun 24, 2026 | Yusheng Han | Buy | 250,000 | $8.00 |
| Jun 24, 2026 | Yusheng Han | Buy | 250,000 | $8.00 |
| Jun 24, 2026 | Yusheng Han | Buy | 250,000 | $8.00 |
| Jun 23, 2026 | Yusheng Han | Buy | 5,990 | $7.50 |
| Jun 23, 2026 | Yusheng Han | Buy | 5,990 | $7.50 |
| Jun 23, 2026 | Yusheng Han | Buy | 5,990 | $7.50 |
| Jun 23, 2026 | Yusheng Han | Buy | 5,990 | $7.50 |
| Jun 22, 2026 | Yusheng Han | Buy | 104,650 | $7.45 |
| Jun 22, 2026 | Yusheng Han | Buy | 104,650 | $7.45 |
| Jun 22, 2026 | Yusheng Han | Buy | 104,650 | $7.45 |
BNR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
BNR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Services-Medical Laboratories
Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BNR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.